enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed May 15, 2026

Form type

SCHEDULE 13G/A

Filing date

May 15, 2026

Accession number

0001172661-26-002215

Filer

enGene Therapeutics Inc. (CIK 1980845)